Radi-oncology, also known as radiotherapy, is a method of treating cancer by exposing a specific part of the body to high-intensity X-rays, which are directed precisely at the tumour.
Radio-oncology is a multi-disciplinary treatment that brings together radiologists, nuclear medicine specialists, pathologists, radio-oncologists, oncologists and surgeons, who discuss each case in detail at weekly colloquia, also known as Tumour Boards, in order to jointly determine the best possible treatment option. Support care is provided in parallel, focusing on the coordinated management of disease-related difficulties.
Radio-oncology treatment uses a particle accelerator. This device delivers rays, or ionising radiation, in a highly targeted manner to the tumour volume; these rays will damage the DNA of the cancer cells, thus destroying them or preventing their progression, while sparing the peripheral healthy tissue.
Only 4 radiotherapy centres are equipped with a CyberKnife® system in Switzerland.
Clinique Générale-Beaulieu has the latest version of the CyberKnife® S7 system with all collimation capabilities (fixed collimators, Iris™ and InCise™) allowing the radiation beam to be shaped to best match the shape of the tumour, thus gaining flexibility and delivering ever more precise treatments, for a wide range of clinical indications.
Clinique Générale-Beaulieu invests in new equipment to guarantee its patients the best care, maximum safety and optimal comfort.
The Radixact® system is an innovative image-guided intensity modulation radiotherapy system, which enables the delivery of extremely precise radiotherapy. With the purchase of this equipment, the Clinique Générale-Beaulieu is enriching its technical support, allowing a greater number of patients to have access to specialised treatments adapted to their individual needs, in a welcoming and considerate environment, conducive to serenity.
The Papillon+™ is a contact radiotherapy device. This means that it works with low-energy X-rays that will remain on the surface of the damaged tissue. The deeper, healthy organs are perfectly spared, so there are no side effects.
This technique is ideal for treating superficial skin tumours, such as basal and squamous cell cancers, as well as keloids. Cutaneous therapy is performed on an outpatient basis.
The second ideal indication for treatment with Papillon+™ is early rectal cancer. Thanks to its targeted endocavitary action, the Papillon+™ technique makes it possible to avoid surgery in certain cases. This promotes organ conservation, enabling patients to continue living as normal a life as possible.
At Clinique Générale-Beaulieu, our oncology centres offer our patients holistic, multidisciplinary care. Focused on health and well-being, our specialists and various therapists work with the patient at every stage: prevention, diagnosis, treatment, follow-up, and return to active life.
Open Monday to Friday 07:30-17:00
Clinique Générale-Beaulieu
Chemin Beau-Soleil 20
1206 Genève
